Clinical Trials Logo
  1. Home
  2. Spasmodic Torticollis
  3. NCT00432341

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Spasmodic Torticollis Clinical Trial

Clinical Trial Summary

The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00432341
Study type Interventional
Source Allergan
Contact
Status Terminated
Phase Phase 4
Start date June 2007
Completion date June 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT00528541 - Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Phase 4
Completed NCT00210431 - Post Marketing Surveillance Study of Dysport
Completed NCT00549341 - PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia Phase 1
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT01859247 - Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study N/A
Completed NCT00165776 - Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis Phase 2
Completed NCT00280384 - An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects Phase 2